| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX010 (ip) | median survival time | alkali diluted with saline | 5.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 2; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | alkali diluted with saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 2; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | alkali diluted with saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 2; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 2; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | alkali diluted with saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 2; 06/06 animals surviving on tox evaluation day (usually day 5) |